Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older). |
Fascioliasis | Phase 4 | Egypt Peru Colombia Vietnam View All |
Study of Out of Specification for Tisagenlecleucel |
B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma | Phase 3 | Japan |
Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments |
Advanced Solid Tumors | Phase 1 | United States Italy Spain Czech Republic Hungary Germany China Hong Kong Belgium Canada Korea, Republic of Taiwan Switzerland View All |
Pediatric Long-Term Follow-up and Rollover Study |
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood, Anaplastic Oligodendroglioma, Glioblastoma, Pilocytic Astrocytoma, Giant Cell Astrocytoma, Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, Angiocentric Glioma, Chordoid Glioma of Third Ventricle, Gangliocytoma, Ganglioglioma, Anaplastic Ganglioglioma, Dysplastic Gangliocytoma of Cerebrellum, Desmoplastic Infantile Astrocytoma and Ganglioglioma, Papillary Glioneuronal Tumor, Rosette-forming Glioneurona Tumor, Central Neurocytoma, Extraventricular Neurocytoma, Cerebellar Liponeurocytoma, Neurofibromatosis Type 1 | Phase 4 | United States |
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, ALL and 1L HR LBCL |
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Large B-cell Lymphoma | Phase 1, Phase 2 | United States Spain Italy Japan Germany France Australia Austria View All |
Long-term Efficacy, Safety and Tolerability of LNP023 in C3G |
C3 Glomerulopathy | Phase 3 | Turkey Japan China Switzerland Argentina Germany Greece United States Netherlands United Kingdom Spain France Israel Italy Brazil View All |
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients |
B-Cell Acute Lymphoblastic Leukemia | Phase 2 | United States Canada Spain Belgium Sweden United Kingdom Italy Norway Netherlands View All |
Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa |
Hidradenitis Suppurativa | Phase 2 | France Spain Germany Belgium United States Hungary Austria View All |
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS |
Relapsing Multiple Sclerosis | Phase 3 | United States Hungary Poland Turkey Bulgaria View All |
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML |
FLT3-mutated Acute Myeloid Leukemia | Phase 2 | Turkey Jordan Germany Italy Czech Republic Poland Slovenia Korea, Republic of Austria View All |